Standigm's alternatives and competitors

See how Standigm compares to similar products. Standigm's top competitors include Recursion Pharmaceuticals, Atomwise, and Owkin.

Recursion (NASDAQ: RXRX) is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a parallel system to ef…

Standigm vs. Recursion Pharmaceuticals

Why does Standigm win vs. Recursion Pharmaceuticals

Technological Lead

Standigm Provides…

Standigm has better productivity than Recursion in pipeline generation
  • Atomwise uses deep learning neural networks to help discover new medicines. Atomwise achieves results for new drug hit discovery, binding affinity prediction, and toxic…

    Standigm vs. Atomwise

    Why does Standigm win vs. Atomwise

    Technological Lead

    Standigm Provides…

    Standigm have better success rate in binding predictability
  • Owkin Logo
    Analyst Briefing Submitted

    Owkin specializes in AI technologies applied to clinical research with the aim of developing better drugs and treatments for patients. The company's purpose is to empow…

    Standigm vs. Owkin

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • Insilico Medicine Logo
    Analyst Briefing Submitted

    Insilico Medicine develops a range of generative adversarial networks (GANs) and reinforcement learning approaches to identify protein targets, generate molecular struc…

    Standigm vs. Insilico Medicine

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • BenevolentAI Logo
    Analyst Briefing Submitted

    BenevolentAI (AMS: BAI) creates and applies AI and machine learning to update the way medicines are discovered and developed. Benevolent integrates its technology into …

    Standigm vs. BenevolentAI

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • Exscientia (NASDAQ: EXAI) is an AI-driven, drug discovery, and design enterprise. Exscientia aims to use AI to discover and design better quality drugs with greater eff…

    Standigm vs. Exscientia

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • insitro Logo
    Analyst Briefing Submitted

    insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created t…

    Standigm vs. insitro

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • CI
    Analyst Briefing Submitted

    CIMPLRX is a drug development company based on artificial intelligence (AI) technology.

    Standigm vs. CIMPLRX

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • Numerate is a privately held biotechnology company that applies machine-learning algorithms, at cloud scale, to overcome major challenges in small molecule drug discove…

    Standigm vs. Numerate

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • Cyclica Logo
    Analyst Briefing Submitted

    Cyclica is a global biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's structure…

    Standigm vs. Cyclica

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • Aria Pharmaceuticals Logo
    Analyst Briefing Submitted

    Aria Pharmaceuticals is a preclinical-stage pharmaceutical company that discovers and develops novel small molecule therapies for complex and hard-to-treat diseases

    Standigm vs. Aria Pharmaceuticals

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • GNS Healthcare applies artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at th…

    Standigm vs. GNS Healthcare

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • Healx Logo
    Analyst Briefing Submitted

    Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Its AI drug discovery platform le…

    Standigm vs. Healx

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations
  • BERG is a Boston-based biopharma company focused on taking a bold "back to biology" approach to therapeutic discovery using its unique AI-based Interrogative Biology pl…

    Standigm vs. BERG

    View Standigm's entire Analyst Briefing

    Standigm's Analyst Briefing includes information on:

    • Pricing
    • Customer references
    • Products
    • Integrations

Work for Standigm?

Compete with Standigm?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

You May Also Like

GNS Healthcare Logo
GNS Healthcare

GNS Healthcare applies artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.

Insilico Medicine Logo
Insilico Medicine

Insilico Medicine develops a range of generative adversarial networks (GANs) and reinforcement learning approaches to identify protein targets, generate molecular structures with specified properties, and generate synthetic data. The company provides pharmaceutical and biotechnology companies with artificial intelligence solutions that transform the way innovative medicines and treatments are discovered and accelerate research and development. The company was founded in 2014 and is based in Hong Kong.

Cyclica Logo
Cyclica

Cyclica is a global biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights.

B
BERG

BERG is a Boston-based biopharma company focused on taking a bold "back to biology" approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This platform combines patient biology and artificial intelligence-based analytics to engage the differences between healthy and disease environments. The patient's own biology drives the platform's results and guides the company in the discovery and development of drugs, diagnostics and healthcare applications. Its platform utilizes patient population health data to bring actionable Patient Intelligence to precision medicine applications. This means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems.

Atomwise Logo
Atomwise

Atomwise uses deep learning neural networks to help discover new medicines. Atomwise achieves results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, start-ups, and research institutions. It is currently using computational drug design to design drugs against COVID.

Healx Logo
Healx

Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Its AI drug discovery platform leverages public and proprietary biomedical data and features a knowledge graph for rare diseases.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.